Specifically, it will be extremely interesting to assess whether subjects who are natural knockouts for ERAP2 expression, because of the rs2248374 polymorphism, display a different susceptibility/progression to OSCC or pancreatic cancer. This evidence concerns the gene ERAP2 and pancreatic neoplasm.